SELLAS Life Sciences Group (SLS) Stock: Buy, Sell, or Hold?
SLS - SELLAS Life Sciences Group, Inc. Common Stock
$11.79
-0.35 (-2.88%)
âŧ
5d:
+3.97%
30d:
+2.34%
90d:
+4.15%
WAIT
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 11, 2026
19d
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Oct 1, 2026 at $11.33 · last confirmed Oct 20, 2026
Strength: 7.9/10
Get Alerted When SLS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: SLS is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: SLS is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: SLS is currently trading at $11.79, which is considered slightly high relative to its 30-day fair value range of $11.10 to $12.06.
Technical Outlook: Technically, SLS is in a uptrend. Immediate support is located at $9.75, while resistance sits at $12.70.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $32.50 (+167.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SLS is in a uptrend. Immediate support is located at $9.75, while resistance sits at $12.70.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $32.50 (+167.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$11.10 -
$12.06
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
66.8%
Protect Your Profits
Holding SLS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 167.7% below Wall St target ($32.50)
- WARNING: Composite score 46/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$11.10 -
$12.06
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$9.75
Resistance Level
$12.70
Current Trend
Uptrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-121.40
Wall Street Target
$32.50
(+167.7%)
Revenue Growth (YoY)
-82.5%
Share & Embed Analysis
Last updated: October 22, 2026 12:09 PM ET
Data refreshes hourly during market hours. Next update: 1:09 PM
Data refreshes hourly during market hours. Next update: 1:09 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SLS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$295 | 62 BUY |
|
REGN
Regeneron PharmaceuticalâĻ |
BUY
28 analysts |
$864 | 44 HOLD |
|
PRAX
Praxis Precision MedicinâĻ |
STRONG BUY
20 analysts |
$650 | 61 BUY |
|
ACAD
ACADIA Pharmaceuticals IâĻ |
STRONG BUY
20 analysts |
$31 | 66 BUY |
|
IMUX
Immunic Inc |
STRONG BUY
12 analysts |
$43 | 70 BUY |
Advanced SLS Option Strategies
Professional options setups generated by AI based on today's SLS price and gamma walls.
